Albemarle anticipates $300M–$400M positive free cash flow in 2025 as cost actions surpass targets (NYSE:ALB)
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...